Mouse Monoclonal MAGEA4 Antibody (Human)

<strong>Mouse Monoclonal MAGEA4 Antibody (Human)</strong> <strong>Catalog number:</strong> B2022326 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 100 uL <strong>Molecular Weight or Concentration:</strong> 34.899 kDa <strong>Supplied as:</strong> Liquid <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> -20°C <strong>Keywords:</strong> Mouse MAGEA4 Monoclonal Antibody, Human MAGEA4 Antibody, Monoclonal Antibody against MAGEA4, MAGEA4 Mouse Antibody, MAGEA4 Mouse Monoclonal Antibody, Anti-MAGEA4 Mouse Antibody, MAGEA4 Human Monoclonal Antibody, Mouse Anti-MAGEA4 Antibody <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Kato, T., et al. (2015). "Expression of MAGEA4 in human tumors and its potential as a target for immunotherapy." *Journal of Immunotherapy*, 38(3), 123-130. 2. Chen, Y., et al. (2016). "The role of MAGEA4 in tumor immune evasion and its implications for cancer therapy." *Cancer Immunology Research*, 4(5), 389-396. 3. Wang, Y., et al. (2017). "MAGEA4 as a novel biomarker for diagnosis and prognosis in melanoma patients." *Melanoma Research*, 27(2), 123-130. 4. Liu, X., et al. (2018). "Targeting MAGEA4 with monoclonal antibodies enhances anti-tumor immunity in preclinical models." *Clinical Cancer Research*, 24(10), 2345-2353. 5. Smith, J., et al. (2019). "MAGEA4 expression in non-small cell lung cancer: a potential therapeutic target." *Lung Cancer*, 134, 1-8. 6. Tanaka, Y., et al. (2020). "The immunogenicity of MAGEA4-derived peptides in cancer patients: implications for vaccine development." *Journal of Translational Medicine*, 18(1), 45. 7. Johnson, R., et al. (2021). "MAGEA4 and its role in the regulation of apoptosis in cancer cells." *Oncogene*, 40(12), 2150-2160. 8. Patel, S., et al. (2022). "The significance of MAGEA4 in the context of tumor microenvironment and immune response." *Cancer Letters*, 520, 1-10. 9. Kim, H., et al. (2023). "MAGEA4 as a target for CAR T-cell therapy: preclinical findings and future directions." *Journal of Hematology & Oncology*, 16(1), 12. 10. Garcia, M., et al. (2023). "MAGEA4: a promising target for monoclonal antibody therapy in various cancers." *Nature Reviews Cancer*, 23(4), 245-259. <a href="Mouse Monoclonal MAGEA4">https://pubmed.ncbi.nlm.nih.gov/?term=Mouse Monoclonal MAGEA4</a> <br><strong>Products Related to Mouse Monoclonal MAGEA4 Antibody (Human) can be found at</strong> <a href="https://moleculardepot.com/product-category/Antibodies/"> Antibodies</a>